Between two giants: Europe’s new oncology chapter takes shape in Paris - Pharmaceutical Technology
Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital and industry converge at Campus Grand Parc. Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital and industry converge at Campus Grand Parc. Professor Fabrice Barlesi of Gustave Roussy outlining Europe’s oncology ambitions at the Kadans Oncology Summit in Paris. Image credit: GlobalData The opening of THE HIVE at Campus Grand Parc was marked not simply by the inauguration of a new laboratory building, but by a broader statement of intent about Europe’s ambitions in oncology and…
Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital and industry converge at Campus Grand Parc.
Source: Pharmaceutical Technology